Evidence map›Paper›PMID 31934863›Full record

ArticleeLife2020

TRF1 averts chromatin remodelling, recombination and replication dependent-break induced replication at mouse telomeres.

Rosa Maria Porreca, Emilia Herrera-Moyano, Eleni Skourti, Pui Pik Law, Roser Gonzalez Franco, Alex Montoya, Peter Faull, Holger Kramer, Jean-Baptiste Vannier

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Cancer-associated TRF1 mutations alter PARP1 interaction dynamics: an in silico study.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  2. Article
  3. Selective loss and transcriptional reprogramming of Nox4The journal of headache and pain · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rosa Maria PorrecaTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Emilia Herrera-MoyanoTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Eleni SkourtiTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Pui Pik LawTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.ORCID https://orcid.org/0000-0001-8924-0462
Roser Gonzalez FrancoTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Alex MontoyaBiological Mass Spectrometry and Proteomics, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Peter FaullBiological Mass Spectrometry and Proteomics, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.ORCID https://orcid.org/0000-0001-8491-8086
Holger KramerBiological Mass Spectrometry and Proteomics, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.
Jean-Baptiste VannierTelomere Replication and Stability group, Medical Research Council - London Institute of Medical Sciences, London, United Kingdom.ORCID https://orcid.org/0000-0002-4471-1854
Imperial College London · GBMedical Research Council · GBThe Francis Crick Institute · GB

Funding

European Commission 637798 MetDNASecStrMedical Research Council MC_UP_1102/14Medical Research Council MRC Career Development AwardMedical Research Council Telomere Replication and Stability
6 · The paper itself

Abstract

Telomeres are a significant challenge to DNA replication and are prone to replication stress and telomere fragility. The shelterin component TRF1 facilitates telomere replication but the molecular mechanism remains uncertain. By interrogating the proteomic composition of telomeres, we show that mouse telomeres lacking TRF1 undergo protein composition reorganisation associated with the recruitment of DNA damage response and chromatin remodellers. Surprisingly, mTRF1 suppresses the accumulation of promyelocytic leukemia (PML) protein, BRCA1 and the SMC5/6 complex at telomeres, which is associated with increased Homologous Recombination (HR) and TERRA transcription. We uncovered a previously unappreciated role for mTRF1 in the suppression of telomere recombination, dependent on SMC5 and also POLD3 dependent Break Induced Replication at telomeres. We propose that TRF1 facilitates S-phase telomeric DNA synthesis to prevent illegitimate mitotic DNA recombination and chromatin rearrangement.

Indexed as

Chromatin Assembly and DisassemblyDNA BreaksAnimalsCell Cycle ProteinsCell LineChromatinDNADNA Polymerase IIIDNA ReplicationGene DeletionHumansInclusion BodiesMiceMitosisRecombination, GeneticTelomereCell Cycle ProteinsChromatinDNADNA Polymerase IIIPOLD3 protein, mouseSMC5 protein, mouseTelomeric Repeat Binding Protein 1ALTcell biologychromosomesDNA damage responseDNA recombinationgene expressionhumanmousereplicationtelomereTERRA

Identifiers

PMID31934863
PMCPMC6986873
OpenAlexW2998845731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.